Serum Podocalyxin Level as a Potential Biomarker for Diagnosis of Nephrotic Syndrome and Prediction of Steroid Response.

Also, its median level at diagnosis was numerically higher in patients who developed SDNS than in patients who never relapsed; however, this difference did not reach statistical significance [1.95 ng/dL (IQR: 1.17) vs. 1.65 ng/dL (IQR: 0.92), p=0.148].

also in 111,027 other papers

Notably, serum podocalyxin levels at diagnosis were markedly elevated in NS compared with controls and showed a nonsignificant trend toward higher values in those who progressed to SDNS and required more intensive treatment.

also in 5,406 other papers